< (0.999) Graft (0.698) (0.483) <0.001 (0.698) (<0.001) (<0.001) 3 months (0.999) (0.483) (<0.001) 6 months (<0.

Σχετικά έγγραφα
SABiosciences PCR Array Catalog #: PAHS-021 SA+ SCF 4h stimulaton AVG(Ct) Position Unigene Refseq Symbol Description shcontr shcontr-4h shgskβ A01

Group 2 Methotrexate 7.5 mg/week, increased to 15 mg/week after 4 weeks. Methotrexate 7.5 mg/week, increased to 15 mg/week after 4 weeks

Supplemental tables and figures

Η ΦΛΕΓΜΟΝΩ ΗΣ ΑΝΤΙ ΡΑΣΗ ΤΟΥ ΓΑΣΤΡΙΚΟΥ ΒΛΕΝΝΟΓΟΝΟΥ ΣΤΗ ΛΟΙΜΩΞΗ ΜΕ ΕΛΙΚΟΒΑΚΤΗΡΙ ΙΟ ΤΟΥ ΠΥΛΩΡΟΥ ΠΡΙΝ ΚΑΙ ΜΕΤΑ ΤΗ ΘΕΡΑΠΕΙΑ

Supplementary figures

BD Cytometric Bead Array Flex Set System

5- CACGAAACTACCTTCAACTCC-3 beta actin-r 5- CATACTCCTGCTTGCTGATC-3 GAPDH-F GAPDH-R

Υπέρταση και Διατροφή

GDF-15 is a predictor of cardiovascular events in patients presenting with suspicion of ACS

ΜΕΤΑΒΟΛΙΚΟ ΣΥΝΔΡΟΜΟ ΣΕ ΠΑΙΔΙΑΤΡΙΚΟΥΣ ΑΣΘΕΝΕΙΣ ΜΕ ΑΠΛΗ ΠΑΧΥΣΑΡΚΙΑ ΚΑΙ ΔΙΑΒΗΤΟ-ΠΑΧΥΣΑΡΚΙΑ (DIABESITY) Α. Γαλλή-Τσινοπούλου

ΔΙΔΑΚΤΟΡΙΚΗ ΔΙΑΤΡΙΒΗ ΓΕΩΡΓΙΟΣ ΙΩΑΝΝΟΥ ΠΑΠΑΧΡΗΣΤΟΥ

α α Pneumocystis jirovecii

ΤΟΥ ΑΜΦΙΒΛΗΣΤΡΟΕΙΔΗ ΣΤΟ ΔΙΑΒΗΤΙΚΟ ΟΙΔΗΜΑ ΜΕ ΟΠΤΙΚΗ ΤΟΜΟΓΡΑΦΙΑ ΣΥΝΟΧΗΣ - OCT) ιάφας Σ., Κωτσίδης Σ., Χατζητόλιος Α. Κατσίκη Ν.,

FORMULAS FOR STATISTICS 1

Aquinas College. Edexcel Mathematical formulae and statistics tables DO NOT WRITE ON THIS BOOKLET

ΠΕΡΙΕΧΟΜΕΝΑ 1 ΕΙΣΑΓΩΓΗ ΤΟ PASW ΜΕ ΜΙΑ ΜΑΤΙΑ ΠΕΡΙΓΡΑΦΙΚΗ ΣΤΑΤΙΣΤΙΚΗ: Η ΜΕΣΗ ΤΙΜΗ ΚΑΙ Η ΔΙΑΜΕΣΟΣ... 29

Statistics 104: Quantitative Methods for Economics Formula and Theorem Review

Simon et al. Supplemental Data Page 1

Λαμβάνοντας αποφάσεις στο γλαύκωμα ΕΟΠ, Οπτικά πεδία, Απεικονιστικά

Supplementary Materials: A Preliminary Link between Hydroxylated Metabolites of Polychlorinated Biphenyls and Free Thyroxin in Humans

Οστεοποντίνη στο υπερκείµενο των προκλητών πτυέλων σε ασθµατικούς καπνιστές: συσχετίσεις µε δείκτες φλεγµονής και αναδιαµόρφωσης των αεραγωγών

Supplementary Information 1.

encouraged to use the Version of Record that, when published, will replace this version. The most /BCJ

Si + Al Mg Fe + Mn +Ni Ca rim Ca p.f.u

Supporting Information

Does anemia contribute to end-organ dysfunction in ICU patients Statistical Analysis

Προενταξιακός ασθενής - Επιλογή μεθόδου κάθαρσης

Biostatistics for Health Sciences Review Sheet

Supplemental Table 1. ICD-9-CM codes and ATC codes used in this study

Διδακτορική Διατριβή

Τα ηπατικά επίπεδα του FOXP3 mrna στη χρόνια ηπατίτιδα Β εξαρτώνται από την έκφραση των οδών Fas/FasL και PD-1/PD-L1


Optimizing Microwave-assisted Extraction Process for Paprika Red Pigments Using Response Surface Methodology

APPENDICES APPENDIX A. STATISTICAL TABLES AND CHARTS 651 APPENDIX B. BIBLIOGRAPHY 677 APPENDIX C. ANSWERS TO SELECTED EXERCISES 679

Ενδοθηλιακή δυστροφία του Fuchs και καταρράκτης

Οι κλασικοί παράγοντες καρδιαγγειακού κινδύνου εξηγούν εν μέρει την. αυξημένη συχνότητα των μακροαγγειοπαθητικών επιπλοκών στα άτομα με

Escherichia coli. Escherichia coli Proteus mirabilis Klebsiella pneumoniae

Σ.Δ.Η. ΚΡΖΣΖ ΣΜΖΜΑ ΓΗΑΣΡΟΦΖ ΚΑΗ ΓΗΑΗΣΟΛΟΓΗΑ ΠΣΤΥΗΑΚΖ ΔΡΓΑΗΑ

ΕΠΙΔΡΑΣΗ ΤΩΝ ΜΑΚΡΟΘΡΕΠΤΙΚΩΝ ΣΥΣΤΑΤΙΚΩΝ ΣΤΗΝ ΑΝΤΙΣΤΑΣΗ ΣΤΗΝ ΙΝΣΟΥΛΙΝΗ ΚΑΙ ΤΙΣ ΑΠΑΙΤΗΣΕΙΣ ΣΕ ΙΝΣΟΥΛΙΝΗ

ΣΚΟΛΙΩΣΗ ΚΑΙ ΣΥΓΓΕΝΕΙΣ ΚΑΡΔΙΟΠΑΘΕΙΕΣ

THICK FILM LEAD FREE CHIP RESISTORS

Έλεγχος ύπαρξης στατιστικά σημαντικών διαφορών μεταξύ δύο ανεξάρτητων δειγμάτων, που δεν ακολουθούν την κανονική κατανομή (Mann Whitney U τεστ)


Cellular Physiology and Biochemistry

Contents Part I Psychoneuroimmunology and Systems Biology Mechanisms 1 From Psychoneuroimmunology to Personalized, Systems, and Dynamical Medicine

IOL PPL+PPV+IOL. Phaco+CTR+IOL. Phaco+CTR+ IOL PPL+PPV+IOL P=0.02 Phaco+CTR+IOL CTR P=0.98 PPL+PPV+IOL CTR

5.4 The Poisson Distribution.

A strategy for the identification of combinatorial bioactive compounds. contributing to the holistic effect of herbal medicines

MSM Men who have Sex with Men HIV -

Aluminum Electrolytic Capacitors (Large Can Type)

IV. ANHANG 179. Anhang 178

Supplementary Figure 1

Ο πολυµορφισµός -174 G>C του γονιδίου της ΙL-6. σχετίζεται µε µεσοπρόθεσµη αγγειογραφική εξέλιξη. των µη-ένοχων βλαβών σε ασθενείς µε γνωστή

Spatiotemporal footprint of the WNV in Greece : Analysis & Risk Αssessment in a GIS Εnvironment

Supplementary Appendix

ΣΧΕΔΙΑΣΜΟΣ. ΠΟΛΥΞΕΝΗ ΗΛΙΟΠΟΥΛΟΥ Αγρονόμος-Τοπογράφος Μηχ. Δρ. Γεωγραφίας Καθηγήτρια Τμ. Τοπογραφίας ΤΕΙ ΑΘΗΝΑΣ

Supplementary Table 1. Primers used for RT-qPCR analysis of striatal and nigral tissue.

SECTION II: PROBABILITY MODELS

Supporting Information

Relationship between Connective Tissue Diseases and Thyroid Diseases

Φ. Μητροπούλου, Μ. Σαλούρου, Κ. Τούτουζας A Πανεπιστημιακή Καρδιολογική Κλινική Ιπποκράτειο Νοσοκομείο

ΜΕΛΕΤΗ ΣΥΣΧΕΤΙΣΗΣ ΤΟΥ ΠΟΛΥΜΟΡΦΙΣΜΟΥ RS ΜΕ ΤΗΝ ΚΟΛΠΙΚΗ ΜΑΡΜΑΡΥΓΗ ΣΕ ΕΛΛΗΝΙΚΟ ΠΛΗΘΥΣΜΟ

H επίδραση της γονικής παρουσίας και του παιχνιδιού σε επώδυνες διαδικασίες στα παιδιά

ΔΕΙΚΤΕΣ ΦΛΕΓΜΟΝΗΣ ΣΕ ΑΣΘΕΝΕΙΣ ΜΕ ΜΗ ΑΛΛΕΡΓΙΚΟ ΣΟΒΑΡΟ ΒΡΟΓΧΙΚΟ ΑΣΘΜΑ

ΑΛΕΞΑΝ ΡΕΙΟ ΤΕΧΝΟΛΟΓΙΚΟ ΕΚΠΑΙ ΕΥΤΙΚΟ Ι ΡΥΜΑ ΘΕΣΣΑΛΟΝΙΚΗΣ ΓΝΩΣΕΙΣ ΙΑΒΗΤΗ, ΓΛΥΚΑΙΜΙΚΟΣ ΕΛΕΓΧΟΣ ΚΑΙ ΙΑΤΡΟΦΗ ΙΑΒΗΤΙΚΩΝ ΕΝΗΛΙΚΩΝ ΝΟΜΟΥ ΑΙΤΩΛΟΑΚΑΡΝΑΝΙΑΣ

τατιστική στην Εκπαίδευση II

ΠΑΝΕΠΙΣΤΗΜΙΟ ΠΑΤΡΩΝ ΣΧΟΛΗ ΕΠΙΣΤΗΜΩΝ ΥΓΕΙΑΣ ΤΜΗΜΑ ΙΑΤΡΙΚΗΣ ΠΡΟΓΡΑΜΜΑ ΜΕΤΑΠΤΥΧΙΑΚΩΝ ΣΠΟΥ ΩΝ ΣΤΙΣ ΚΛΙΝΙΚΕΣ ΚΛΙΝΙΚΟΕΡΓΑΣΤΗΡΙΑΚΕΣ ΙΑΤΡΙΚΕΣ ΕΙ ΙΚΟΤΗΤΕΣ

Aluminum Electrolytic Capacitors

Electronic Supplementary Information (ESI)

ΚΕΧΑΓΙΑΣ ΒΑΣΙΛΕΙΟΣ ΑΘΗΝΑ, 16/11/10 A.M. :

Μελέτη της έκφρασης του ογκοκατασταλτικού γονιδίου Cyld στον καρκίνο του μαστού

Μελέτη της αυτοδιαχείρισης του διαβήτη με την εφαρμογή ειδικού ερωτηματολογίου σε παιδιά και εφήβους με σακχαρώδη διαβήτη τύπου 1

ΚΕΡΚΙΔΙΚΗ ΚΑΙ ΜΗΡΙΑΙΑ ΠΡΟΣΠΕΛΑΣΗ ΣΕ ΣΤΕΦΑΝΙΟΓΡΑΦΙΕΣ ΚΑΙ ΑΓΓΕΙΟΠΛΑΣΤΙΚΕΣ. ΜΙΑ ΣΥΓΚΡΙΤΙΚΗ ΜΕΛΕΤΗ

ο),,),--,ο< $ι ιι!η ι ηι ι ιι ιι t (t-test): ι ι η ι ι. $ι ι η ι ι ι 2 x s ι ι η η ιη ι η η SE x

Focal Length. Max. Aperture Ratio 1:1.4. Focus 0.3m - 0.9m. Object Dimension at M.O.D. 40.7(H)cm x 30.4(V)cm 1/2" 76.7 V

129.2± ± ±0.4 9

Οδηγίες χρήσης του R, μέρος 2 ο

ΠΑΝΕΠΙΣΤΗΜΙΟ ΘΕΣΣΑΛΙΑΣ

Proprotein convertase subtilisin / kexin type 9 interaction with plasma lipoproteins in subjects with high Lipoprotein (a) levels

PENGARUHKEPEMIMPINANINSTRUKSIONAL KEPALASEKOLAHDAN MOTIVASI BERPRESTASI GURU TERHADAP KINERJA MENGAJAR GURU SD NEGERI DI KOTA SUKABUMI

2. Η Βαρύτητα Διαφόρων Γλυκαιμικών Δεικτών Νοσηλείας στην Λειτουργική Έκβαση του ΑΕΕ των Διαβητικών Ασθενών

ΠΕΡΙΕΧΟΜΕΝΑ 1 ΕΙΣΑΓΩΓΗ ΤΟ PASW ΜΕ ΜΙΑ ΜΑΤΙΑ ΠΕΡΙΓΡΑΦΙΚΗ ΣΤΑΤΙΣΤΙΚΗ: Η ΜΕΣΗ ΤΙΜΗ ΚΑΙ Η ΔΙΑΜΕΣΟΣ... 29

ΙΔΡΥΜΑ. Θεσσαλονίκη, ύλα

Supplementary Table 1. Demographic characteristics of the included ADNI subjects. rfmri. MMSE tics (n=907; (n=1092; n long =107.

Applications. 100GΩ or 1000MΩ μf whichever is less. Rated Voltage Rated Voltage Rated Voltage

ΟΣΤΕΟΧΡΟΝΟΛΟΓΗΣΗ Εικόνα 27 Figure 27 Εικόνα 28 Figure 28

BGP TRACP-5b BGP TRACP-5b P 0.05

Bayesian SEM: A more flexible representation of substantive theory Web tables

Διερεύνηση και αξιολόγηση μεθόδων ομογενοποίησης υδροκλιματικών δεδομένων ΔΙΠΛΩΜΑΤΙΚΗ ΕΡΓΑΣΙΑ

ΜΔΛΔΣΖ ΔΝΓΟΣΡΑΥΤΝΖ Δ ΥΑΛΤΒΔ ΘΔΡΜΖ ΔΛΑΖ

Queensland University of Technology Transport Data Analysis and Modeling Methodologies

Πρότυπο ΟΦΘΑΛΜΙΑΤΡΕΙΟ ΘΕΣΣΑΛΟΝΙΚΗΣ Ιωαννίδης Γεώργιος MD

Characterization Report

Long 3000 hour life at 105 C with high ripple current capability 2 and 3 pin versions available Can vent construction

Α Πανεπιστημιακή Καρδιολογική Κλινική, Ιπποκράτειο Νοσοκομείο Αθηνών

SUPPLEMENTAL DATA GWAS of butyrylcholinesterase activity identifies four novel loci, independent effects within BCHE

A life-table metamodel to support management of data deficient species, exemplified in sturgeons and shads. Electronic Supplementary Material

Ι. ΟΙΚΟΝΟΜΙΔΗΣ 1, Γ. ΠΑΥΛΙΔΗΣ 1, Β. ΛΑΜΠΑΔΙΑΡΗ 2, Φ. ΚΟΥΣΑΘΑΝΑ 2, Ε. ΤΡΙΑΝΤΑΦΥΛΛΙΔΗ 1, Μ. ΒΑΡΟΥΔΗ 1, Γ. ΔΗΜΗΤΡΙΑΔΗΣ 2, Ι.

UDZ Swirl diffuser. Product facts. Quick-selection. Swirl diffuser UDZ. Product code example:

Debashish Sahay. To cite this version: HAL Id: tel

Transcript:

Supplementary table 1. Correlation of endothelial cell density among graft, 3, 6, and 12 months after Descemet s automated stripping endothelial keratoplasty. Graft 3 months 6 months 12 months Graft <0.001 0.091 0.050 (0.999) (0.483) (0.698) 3 months <0.001 0.859 0.723 (0.999) (<0.001) (<0.001) 6 months 0.091 0.859 0.898 (0.483) (<0.001) (<0.001) 12 months 0.050 0.723 0.898 (0.698) (<0.001) (<0.001) Correlation coefficient* (P value) *Spearman correlation analysis

Supplementary table 2. Preoperative aqueous cytokine levels stratified by endothelial cell density of 1,200 cells/mm 2 at 12 months after Descemet s automated stripping endothelial keratoplasty. Control (N=33) ECD 1200 (N=35) ECD < 1200 (N=29) P value P value P value P value* Protein 0.31 ± 0.23 0.94± 0.84 1.31 ± 0.79 0.003 <0.001 0.18 <0.001 IL-1α 49.3 ± 25.5 68.7 ± 48.1 99.5 ± 99.7 0.20 0.17 >0.99 0.032 IL-1β 3.1 ± 10.1 2.5 ± 3.0 7.8 ± 12.9 >0.99 0.17 0.72 0.303 IL-4 20.5 ± 5.8 31.2 ± 17.4 52.9 ± 50.6 0.008 <0.001 0.52 0.005 IL-6 85 ± 399 956 ± 1371 1915 ± 3536 <0.001 <0.001 >0.99 <0.001 IL-8 46.4 ± 146 80.7 ± 115.6 83.4 ± 96.5 0.005 0.012 >0.99 0.002 IL-10 1.9 ± 0.7 3.6 ±2.2 14.7 ± 33.5 <0.001 0.004 >0.99 <0.001 IL-12p70 6.4 ± 0.9 10.9 ± 6.6 15.3 ± 12.9 0.003 <0.001 >0.99 0.001 IL-13 7.1 ± 1.4 9.7 ± 4.7 9.8 ± 5.1 0.045 0.018 >0.99 0.007 IL-17A 4.0 ±2.1 8.3 ± 10.7 11.8 ± 10.3 0.014 <0.001 0.39 0.001 MIP-1α 9.4 ± 2.5 14.1 ± 8.1 16.8 ± 21.7 0.54 >0.99 0.63 0.047 MIP-1β 345 ± 116 298.2 ±283.7 389 ± 626 0.55 0.44 >0.99 0.237 MCP-1 592 ± 485 705.1 ± 668.3 1283 ± 830 0.39 <0.001 0.01 <0.001 TNF-α 76.4 ± 31.2 162 ± 178 114 ± 99 0.006 0.51 0.39 0.001 IFN-α 4.1 ± 0.7 5.3 ± 3.2 5.3 ± 4.2 0.51 0.91 >0.99 0.141 IFN -γ 55.6 ± 11.9 74.8 ± 47.7 132 ± 122 0.47 <0.001 0.02 <0.001 E-Selectin 2149 ± 264 3737 ± 2287 4836 ± 5070 <0.001 <0.001 >0.99 <0.001 P-Selectin 3724 ± 753 8679 ± 7737 13556 ± 17279 <0.001 <0.001 0.28 <0.001 sicam-1 2027 ± 2585 3375 ± 2659 6920 ± 6596 0.046 <0.001 0.13 <0.001 IP10 257 ± 514 174 ± 142 380 ± 458 0.85 0.25 >0.99 0.192 Mean ± SD Protein:(mg/ml), Cytokines:(pg/ml) Mann-Whitney U test, compared ECD 1200 group to control group. Mann-Whitney U test, compared ECD < 1200 group to control group. Mann-Whitney U test, compared ECD < 1200 group to ECD 1200 group. *Trends test ECD: endothelial cell density, IL: interleukin, MIP: macrophage inflammatory protein, MCP: monocyte chemotactic protein, TNF: tumor necrosis factor, GM-CSF: granulocyte-macrophage colony-stimulating factor, IFN: interferon, sicam: soluble intracellular adhesion molecule, IP10: interferon gamma-induced protein 10

Supplementary table 3. Preoperative aqueous protein and cytokine levels stratified by endothelial cell density of 1,000 and 2,000 cells/mm 2 at 12 months after Descemet s automated stripping endothelial keratoplasty. Aqueous Control ECD 2000 1000 ECD < 2000 ECD < 1000 P value P value P value P value P value* P value# P value* cytokine N=33 N=9 N=34 N=21 Protein 0.31 (0.23) 0.91 (0.72) 1.08 (0.88) 1.34 (0.78) - - - - - - <0.001 IL-1α 49.3 (25.5) 80.4 (30.7) 72.3 (51.5) 108.4 (118.2) 0.13 0.25 >0.99 >0.99 0.98 >0.99 0.243 IL-1β 3.1 (10.1) 3.7 (4.5) 3.3 (6.1) 8.91 (13.9) >0.99 >0.99 0.132 >0.99 >0.99 0.55 0.091 IL-4 20.5 (5.8) 38.7 (18.7) 31.2 (17.3) 61.7 (57.4) 0.019 0.011 <0.001 >0.99 >0.99 0.97 <0.001 IL-6 6.4 (0.9) 673 (942) 1170 (1676) 2318 (3996) 0.001 <0.001 <0.001 >0.99 >0.99 >0.99 <0.001 IL-8 19.3 (1.2) 61.4 (82.5) 93.0 (127.9) 85.9 (87.8) 0.63 0.001 0.008 >0.99 >0.99 >0.99 <0.001 IL-10 1.9 (0.7) 3.7 (1.6) 4.5 (4.2) 18.2 (39.1) 0.02 <0.001 0.02 >0.99 >0.99 >0.99 <0.001 IL-12p70 6.4 (0.9) 12.1 (7.3) 10.0 (6.12) 18.2 (14.1) 0.09 0.04 <0.001 >0.99 >0.99 0.13 <0.001 IL-13 7.1 (1.4) 10.1 (2.6) 9.6 (4.8) 10.3 (5.9) 0.17 0.099 0.067 >0.99 >0.99 >0.99 0.004 IL-17A 4.0 (2.1) 6.9 (5.3) 8.4 (10.5) 14.3 (11.4) 0.82 0.009 <0.001 >0.99 0.57 0.64 <0.001 MIP-1α 9.4 (2.5) 15.5 (10.2) 13.1 (7.3) 19.1 (25.2) >0.99 0.627 >0.99 >0.99 >0.99 >0.99 0.366 MIP-1β 345 (116) 353 (297) 323 (286) 400 (721) >0.99 >0.99 0.35 >0.99 >0.99 >0.99 0.058 MCP-1 449 (24) 950 (1182) 734 (581) 1387 (777) >0.99 0.79 <0.001 >0.99 0.26 0.004 <0.001 TNF-α 76.4 (31.2) 163 (122) 153 (169) 120 (122) 0.69 0.006 >0.99 >0.99 >0.99 0.36 0.050 IFN-α 4.1 (0.7) 5.2 (3.3) 5.1 (3.0) 5.7 (4.8) 0.63 >0.99 >0.99 >0.99 >0.99 >0.99 0.318 IFN -γ 55.6 (11.9) 91.0 (48.4) 69.0 (42.7) 156 (136) 0.14 >0.99 <0.001 0.51 >0.99 <0.001 <0.001 E-Selectin 2149 (264) 4964 (2858) 3353 (1988) 5456 (5588) <0.001 <0.001 <0.001 0.67 >0.99 0.27 <0.001 P-Selectin 3724 (752) 11368 (10917) 10328 (14918) 11469 (11088) 0.047 <0.001 <0.001 >0.99 >0.99 0.61 <0.001 sicam-1 2027(2585) 4276 (3248) 3729 (4134) 7761 (6427) 0.13 0.15 <0.001 >0.99 >0.99 0.06 <0.001 IP10 257 (514) 158 (152) 252 (323) 341 (410) >0.99 0.91 0.77 >0.99 >0.99 >0.99 0.168 Mean (SD) Protein:(mg/ml), Cytokines:(pg/ml) Mann-Whitney U test, compared ECD > 2000 group to control group. Mann-Whitney U test, compared 1000 < ECD < 2000 group to control group. Mann-Whitney U test, compared ECD < 1000 group to control group. Mann-Whitney U test, compared ECD > 2000 group to 1000 < ECD < 2000 group *Mann-Whitney U test, compared ECD > 2000 group to ECD < 1000 group #Mann-Whitney U test, compared 1000 < ECD < 2000 group to ECD < 1000 group, *trends test ECD: endothelial cell density, IL: interleukin, MIP: macrophage inflammatory protein, MCP: monocyte chemotactic protein, TNF: tumor necrosis factor, IFN: interferon, sicam: soluble intracellular adhesion molecule, IP10: interferon gamma-induced protein 10

Supplementary table 4. Correlation between preoperative cytokine levels and percentage of endothelial cell density loss. %ECD loss at 6 months %ECD loss at 12months r P value 95% CI r P value 95% CI Protein 0.293 0.053 0.087 to 0.636 0.320 0.041 0.005 to 0.578 IL-1α -0.270 0.066-0.428 to 0.187-0.148 0.321-0.202 to 0.407 IL-1β 0.058 0.706-0.240 to 0.389-0.027 0.858-0.162 to 0.440 IL-4 0.093 0.481-0.259 to 0.287 0.289 0.031 0.021 to 0.519 IL-6-0.007 0.961-0.350 to 0.192 0.047 0.727-0.131 to 0.404 IL-8 0.021 0.874-0.312 to 0.233 0.085 0.528-0.216 to 0.328 IL-10-0.069 0.602-0.312 to 0.233 0.039 0.775 0.028 to 0.529 IL-12p70 0.103 0.446-0.229 to 0.331 0.272 0.047-0.003 to 0.444 IL-13 0.060 0.720-0.270 to 0.411 0.070 0.680-0.257 to 0.424 IL-17A 0.355 0.021 0.049 to 0.601 0.380 0.013 0.087 to 0.619 MIP-1α -0.289 0.067-0.507 to 0.132-0.198 0.215-0.245 to 0.407 MIP-1β -0.250 0.063-0.446 to 0.103-0.141 0.309-0.249 to 0.318 MCP-1 0.303 0.022 0.038 to 0.528 0.470 0.0002 0.232 to 0.656 TNF-α -0.178 0.260-0.411 to 0.241-0.155 0.328-0.490 to 0.136 IFN-α 0.358 0.158-0.440 to 0.227 0.404 0.109-0.308 to 0.358 IFN -γ 0.218 0.049-0.007 to 0.495 0.392 0.0026 0.139 to 0.597 E-Selectin 0.286 0.039 0.006 to 0.524 0.293 0.0352 0.0133 to 0.530 P-Selectin 0.093 0.482-0.201 to 0.333 0.050 0.710-0.249 to 0.297 sicam-1 0.291 0.028 0.06 to 0.519 0.355 0.0068 0.096 to 0.569 IP10-0.075 0.570-0.302 to 0.243-0.023 0.862-0.059 to 0.462 *Spearman s correlation analysis IL: interleukin, MIP: macrophage inflammatory protein, MCP: monocyte chemotactic protein, TNF: tumor necrosis factor, IFN: interferon, sicam: soluble intracellular adhesion molecule, IP10: interferon gamma-induced protein 10

Supplementary table 5. Correlation between preoperative cytokine levels and endothelial cell density in eyes after cataract surgery. %ECD loss at 6 months Cataract surgery ECD at 6 months r P value* r P value* Protein 0.231 0.519 0.171 0.589 IL-1α 0.200 0.557 0.100 0.766 IL-1β 0.073 0.833-0.137 0.677 IL-4 0.018 0.972-0.077 0.811 IL-6 0.330 0.322-0.220 0.498 IL-8 0.169 0.619-0.228 0.489 IL-10 0.136 0.693-0.018 0.967 IL-12p70 0.245 0.468 0.109 0.755 IL-13 0.164 0.634 0.055 0.881 IL-17A 0.005 0.995-0.091 0.781 MIP-1α 0.273-0.221 0.064 0.854 MIP-1β 0.091 0.796 0.273 0.418 MCP-1 0.136 0.694 0.193 0.572 TNF-α 0.264 0.435-0.055 0.881 IFN-α 0.255 0.451-0.164 0.634 IFN -γ 0.110 0.587 0.055 0.881 E-Selectin 0.227 0.503 0.209 0.539 P-Selectin 0.046 0.902 0.193 0.572 sicam-1 0.255 0.451 0.046 0.903 IP10 0.355 0.286 0.073 0.839 *Spearman s correlation analysis IL: interleukin, MIP: macrophage inflammatory protein, MCP: monocyte chemotactic protein, TNF: tumor necrosis factor, IFN: interferon, sicam: soluble intracellular adhesion molecule, IP10: interferon gamma-induced protein 10

Supplementary table 6. Multivariate analysis: history of trabeculectomy was associated with postoperative endothelial cell density. ECD at 3 months ECD at 6 months ECD at 12 months β P value β P value β P value Trabeculectomy -0.352 0.011-0.287 0.028-0.278 0.026 Laser iridotomy 0.038 0.776-0.230 0.076-0.300 0.018 Lens status -0.098 0.478-0.100 0.445-0.216 0.085 Graft size 0.085 0.512 0.141 0.258 0.192 0.105 Preop steroid use -0.062 0.650 0.046 0.731-0.058 0.646 Adjusted R 2 0.114 0.169 0.278 VIF = 1.14 * Lens status, laser iridotomy and history of trabeculectomy were dichotomized as categorical variables for multivariate regression analysis as follows: history of trabeculectomy: absence = 0, presence = 1, laser iridotomy: absence = 0, presence = 1, lens status: phakia = 0, pseudophakia = 1 ECD: endothelial cell density, VIF: variance inflation factor

Supplementary table 7. Correlation between preoperative cytokine levels and percentage of endothelial cell density loss in eyes excluding Fuchs endothelial corneal dystrophy. %ECD loss at 6 months %ECD loss at 12months r P value 95% CI r P value 95% CI Protein 0.227 0.203-0.136 to 0.537 0.258 0.135-0.093 to 0.552 IL-1α -0.303 0.092-0.596 to 0.062-0.207 0.274-0.522 to 0.157 IL-1β 0.034 0.861-0.347 to 0.405 0.062 0.746-0.315 to 0.422 IL-4 0.251 0.123-0.080 to 0.532 0.417 0.010 0.097 to 0.658 IL-6-0.053 0.735-0.369 to 0.270 0.040 0.801-0.276 to 0.348 IL-8-0.028 0.865-0.345 to 0.295 0.081 0.612-0.238 to 0.383 IL-10-0.064 0.696-0.376 to 0.262 0.085 0.594-0.234 to 0.387 IL-12p70 0.265 0.108-0.069 to 0.546 0.375 0.0266 0.037 to 0.636 IL-13 0.255 0.108-0.159 to 0.592 0.309 0.127-0.101 to 0.629 IL-17A 0.606 0.0008 0.282 to 0.805 0.582 0.0014 0.249 to 0.792 MIP-1α -0.350 0.068-0.646 to 0.038-0.311 0.109-0.620 to 0.082 MIP-1β -0.288 0.075-0.560 to 0.039-0.108-0.503-0.410 to 0.216 MCP-1 0.424 0.0079 0.122 to 0.661 0.616 <0.0001 0.360 to 0.785 TNF-α -0.109 0.567-0.460 to 0.272-0.198 0.295-0.529 to 0.196 IFN-α -0.289 0.143-0.611 to 0.113-0.120 0.552-0.487 to 0.284 IFN -γ 0.479 0.0023 0.179 to 0.698 0.623 <0.0001 0.370 to 0.790 E-Selectin 0.564 0.0003 0.280 to 0.758 0.585 0.0002 0.309 to 0.771 P-Selectin 0.122 0.452-0.206 to 0.426 0.178 0.259-0.142 to 0.465 sicam-1 0.356 0.028 0.032 to 0.613 0.506 0.0012 0.213 to 0.716 IP10-0.270 0.093-0.543 to 0.053-0.127 0.423-0.423 to 0.193 *Spearman s correlation analysis IL: interleukin, MIP: macrophage inflammatory protein, MCP: monocyte chemotactic protein, TNF: tumor necrosis factor, GM-CSF: granulocyte-macrophage colony-stimulating factor, IFN: interferon, sicam: soluble intracellular adhesion molecule, IP10: interferon gamma-induced protein 10

Supplementary table 7. Preoperative demographics of DSAEK patients. Solitary Combined P value DSAEK DSAEK # Eyes (n) 43 21 - Sex, n (%) Male 14 (32.6) 7 (33.3) Female 29 (67.4) 14 (66.7) 0.95* Age (y) 74.8 ± 9.5 73.1 ± 9.1 0.38 BCVA (logmar) 1.37 ± 0.60 1.13 ± 0.96 0.08 IOP (mmhg) 13.1 ± 4.2 10.8 ± 3.4 0.01 Axial length (mm) 23.75 ± 2.33 23.40 ± 1.52 0.76 ECD (cells/mm 2 ) NA NA - CCT (μm) 754 ± 122 716 ± 84 0.26 DM, n (%) 6 (14) 4 (19) 0.59* Presence of glaucoma, n (%) 14 (33) 3 (14) 0.12* Number of Previous intraocular surgeries (n) 2.0 ± 1.5 0.5 ± 0.8 <0.001 Mean ± SD DSAEK: Descemet s automated stripping endothelial keratoplasty, SD: standard deviation, BCVA: best-corrected visual acuity, logmar: logarithm of minimal angle resolution, IOP: intraocular pressure, AL: axial length, ECD: endothelial cell density, CCT: central corneal thickness, DM: Diabetes mellitus, IOL: intraocular lens, NA: not available *: Chi-square test # : DSAEK combined with cataract surgery